Mahl Jörg Andreas, Vogel Beate E, Court Mireille, Kolopp Maryelle, Roman Danielle, Nogués Vicente
Novartis Pharma AG, MUT-2881.128, Auhafenstr., CH-4132 Muttenz, Switzerland.
Exp Toxicol Pathol. 2006 Jul;57(5-6):341-5. doi: 10.1016/j.etp.2006.03.004. Epub 2006 May 19.
In view of more morphological and physiological similarities between human and porcine skin than for other laboratory animal species, the minipig is a preferred model to evaluate the safety profile of dermally applied xenobiotics. Different methods of dermal administration and examples of non-invasive and invasive investigations during the in-life phase of the studies are described. Routine and special post-mortem examinations in dermal studies are presented to assess responses to the topical treatment of minipig skin. Challenges in dermal minipig studies are discussed with respect to animal welfare and husbandry, test formulations, application methods and different types of investigations. One of the most significant issues for dermal minipig studies is the extensive measures required to prevent cross-contamination of blood and tissue samples taken to monitor local and systemic exposure to the test item.
鉴于与其他实验动物物种相比,人类和猪的皮肤在形态和生理上有更多相似之处,小型猪是评估经皮应用异种生物安全性的首选模型。本文描述了不同的皮肤给药方法以及研究生命期内非侵入性和侵入性研究的实例。还介绍了皮肤研究中的常规和特殊尸检,以评估小型猪皮肤局部治疗的反应。讨论了小型猪皮肤研究在动物福利和饲养管理、测试制剂、应用方法以及不同类型研究方面面临的挑战。小型猪皮肤研究中最重要的问题之一是,为防止用于监测受试物局部和全身暴露而采集的血液和组织样本发生交叉污染需要采取广泛的措施。